Question

In: Accounting

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:

1

Dec. 31, 20Y3

Dec. 31, 20Y2

2

Assets

3

Cash

$626,170.00

$585,760.00

4

Accounts receivable (net)

227,840.00

208,880.00

5

Inventories

641,390.00

616,790.00

6

Investments

0.00

240,820.00

7

Land

327,380.00

0.00

8

Equipment

704,290.00

554,020.00

9

Accumulated depreciation-equipment

(167,160.00)

(148,930.00)

10

Total assets

$2,359,910.00

$2,057,340.00

11

Liabilities and Stockholders’ Equity

12

Accounts payable (merchandise creditors)

$424,670.00

$404,080.00

13

Accrued expenses payable (operating expenses)

43,080.00

52,050.00

14

Dividends payable

24,920.00

19,300.00

15

Common stock, $2 par

150,000.00

100,000.00

16

Paid-in capital: Excess of issue price over par—common stock

417,500.00

280,000.00

17

Retained earnings

1,299,740.00

1,201,910.00

18

Total liabilities and stockholders’ equity

$2,359,910.00

$2,057,340.00

The income statement for the year ended December 31, 20Y3, is as follows:

1

Sales

$5,367,766.00

2

Cost of goods sold

 3,306,180.00

3

Gross profit

$2,061,586.00

4

Operating expenses:

5

Depreciation expense

$18,230.00

6

Other operating expenses

1,755,888.00

7

Total operating expenses

1,774,118.00

8

Operating income

$287,468.00

9

Other income:

10

Gain on sale of investments

39,070.00

11

Income before income tax

$326,538.00

12

Income tax expense

133,028.00

13

Net income

$193,510.00

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

a. The investments were sold for $279,890 cash.
b. Equipment and land were acquired for cash.
c. There were no disposals of equipment during the year.
d. The common stock was issued for cash.
e. There was a $95,680 debit to Retained Earnings for cash dividends declared.

Prepare a statement of cash flows, using the direct method of presenting cash flows from operating activities. Be sure to complete the heading of the statement. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Enter amounts that represent cash outflows as negative numbers using a minus sign.

Labels and Amount Descriptions

Labels and Amount Descriptions

Cash paid for dividends
Cash paid for purchase of equipment
Cash paid for purchase of land
Cash paid for purchase of treasury stock
Cash payments for income taxes
Cash payments for merchandise
Cash payments for operating expenses
Cash received from customers
Cash received from sale of common stock
Cash received from sale of investments
Change in cash
December 31, 20Y3
Depreciation
For the Year Ended December 31, 20Y3
Gain on sale of investments
Issuance of common stock for acquisition of land
Issuance of common stock for purchase of equipment
Loss on sale of investments
Net cash flow from financing activities
Net cash flow from investing activities
Net cash flow from operating activities
Net cash flow used for financing activities
Net cash flow used for investing activities
Net cash flow used for operating activities

Can you show Calculations thanks

Solutions

Expert Solution

Livers Inc.
Statement of Cash Flows
For the Year Ended December 31, 20Y3
Cash flows from operating activities:
Cash received from customers 5348806.00
Cash payments for merchandise -3310190.00
Cash payments for operating expenses -1764858.00
Cash payments for income taxes -133028.00
Net cash flow from operating activities 140730.00
Cash flows from investing activities:
Cash received from sale of investments 279890.00
Cash paid for purchase of land -327380.00
Cash paid for purchase of equipment -150270.00
Net cash flow used for investing activities -197760.00
Cash flows from financing activities:
Cash received from sale of common stock 187500.00
Cash paid for dividends -90060.00
Net cash flow from financing activities 97440.00
Change in cash 40410.00
Cash at the beginning of the year 585760.00
Cash at the end of the year 626170.00

Calculations:

Cash received from customers
Sales Revenue 5367766.00
Less: Increase in Accounts Receivable -18960.00
5348806.00
Cash payments for merchandise
Cost of goods sold 3306180.00
Add: Increase in Inventory 24600.00
Less: Increase in Accounts Payable -20590.00
3310190.00
Cash payments for operating expenses
Other operating expenses 1755888.00
Add: Decrease in Accrued expenses payable 8970.00
1764858.00
Cash paid for dividends
Dividends payable, beginning balance 19300.00
Add: Dividends declared 95680.00
114980.00
Less: Dividends payable, ending balance -24920.00
90060.00
Cash received from sale of common stock
Common stock, ending balance 150000.00
Paid-in capital, ending balance 417500.00
567500.00
Less: Common stock, beginning balance -100000.00
Less: Paid-in capital, beginning balance -280000.00
187500.00

Related Solutions

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses) 45,000.00 50,000.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses) 42,020.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,170.00 $585,760.00 4 Accounts receivable (net) 227,840.00 208,880.00 5 Inventories 641,390.00 616,790.00 6 Investments 0.00 240,820.00 7 Land 327,380.00 0.00 8 Equipment 704,290.00 554,020.00 9 Accumulated depreciation-equipment (167,160.00) (148,930.00) 10 Total assets $2,359,910.00 $2,057,340.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,670.00 $404,080.00 13 Accrued expenses payable (operating expenses) 43,080.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,170.00 $585,760.00 4 Accounts receivable (net) 227,840.00 208,880.00 5 Inventories 641,390.00 616,790.00 6 Investments 0.00 240,820.00 7 Land 327,380.00 0.00 8 Equipment 704,290.00 554,020.00 9 Accumulated depreciation-equipment (167,160.00) (148,930.00) 10 Total assets $2,359,910.00 $2,057,340.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,670.00 $404,080.00 13 Accrued expenses payable (operating expenses) 43,080.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,820.00 $586,050.00 4 Accounts receivable (net) 227,530.00 209,880.00 5 Inventories 641,480.00 616,920.00 6 Investments 0.00 240,910.00 7 Land 327,510.00 0.00 8 Equipment 704,830.00 554,110.00 9 Accumulated depreciation-equipment (165,750.00) (148,570.00) 10 Total assets $2,361,420.00 $2,059,300.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,970.00 $405,330.00 13 Accrued expenses payable (operating expenses) 42,810.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,650.00 $586,340.00 4 Accounts receivable (net) 228,170.00 208,030.00 5 Inventories 641,480.00 617,130.00 6 Investments 0.00 240,290.00 7 Land 328,170.00 0.00 8 Equipment 706,070.00 552,300.00 9 Accumulated depreciation-equipment (165,580.00) (147,010.00) 10 Total assets $2,363,960.00 $2,057,080.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,300.00 $404,860.00 13 Accrued expenses payable (operating expenses) 41,850.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $262,580 $246,510 Accounts receivable (net) 95,120 88,540 Inventories 268,530 262,130 Investments 0 101,560 Land 137,730 0 Equipment 296,270 231,760 Accumulated depreciation—equipment (69,360) (62,500) Total assets $990,870 $868,000 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $179,350 $171,000 Accrued expenses payable (operating expenses) 17,840 22,570 Dividends payable 9,910 7,810 Common stock, $10 par 53,510 42,530 Paid-in...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT